on 23 Jul 2019
Last Applicant/ Owned by
Blocks A & B Portway Building,
GB
Serial Number
79240294 filed on 09th Mar 2018
Registration Number
5809260 registered on 23rd Jul 2019
Filing Basis
1. filing basis filed as 66 a
Disclaimer
"TARGETED CYTOTOXIN"
Scientific and technological services and research and design relating thereto, namely, scientific research, new product design services, and new study design services in the fields of the development of future human and veterinary medical treatments in the field of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chrRead More
Scientific and technological services and research and design relating thereto, namely, scientific research, new product design services, and new study design services in the fields of the development of future human and veterinary medical treatments in the field of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic preparations and clinical imaging agents; industrial analysis and research services in the fields of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic preparations and clinical imaging agents; information, consultancy and advisory services relating to the aforesaid
Pharmaceutical products, namely, pharmaceutical preparations for use in oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders; pharmaceutical preparations for use as diagnostics, namely, diagnostic preparations for medical use and for use as clinical imaging agents
No 79240294
No Service Mark
No
No
No
No
No
Yes
Yes
No
No
| Status Date | Action Taken |
|---|---|
| 01st Dec 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| 24th Sep 2022 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| 17th Sep 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| 06th Dec 2019 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 18th Nov 2019 | FINAL DISPOSITION PROCESSED |
| 18th Nov 2019 | FINAL DISPOSITION NOTICE SENT TO IB |
| 23rd Oct 2019 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 23rd Jul 2019 | REGISTERED-PRINCIPAL REGISTER |
| 07th May 2019 | PUBLISHED FOR OPPOSITION |
| 07th May 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
